Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DSE Healthcare Solutions is a consumer healthcare company focused on the acquisition and management of specialty over-the-counter (OTC) brands and dietary supplements. The company's portfolio includes well-known legacy brands such as Urinozinc for prostate health, Prelief for dietary acid reduction, and Cystex for urinary tract health. DSE targets niche markets where established brand equity can be leveraged through targeted marketing and distribution. In late 2020, the company was acquired by Bridges Consumer Healthcare, which is backed by the private equity firm Charlesbank Capital Partners. This acquisition aimed to expand Bridges' footprint in the urological and digestive health categories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DSE Healthcare Solutions.